Sonida Senior Living, Inc. (SNDA)
Sonida Senior Living, Inc. owns and operates senior housing communities in the United States. The company provides independent living services, which include daily meals, transportation, social and recreational activities, laundry, housekeeping, and 24-hour staffing; and access to health screenings, periodic special services, and dietary and similar programs, as well as exercise and fitness classes. It offers assisted living services consist of personal care services, such as assistance with activities of daily living, including ambulation, bathing, dressing, eating, grooming, personal hygiene, and monitoring or assistance with medications; support services, such as meals, assistance with social and recreational activities, laundry, general housekeeping, maintenance, and transportation services; and supplemental services, which include extra transportation, personal maintenance, and extra laundry services, as well as special care services for residents with various forms of dementia. In addition, it offers memory care services; and home care services through third-party providers, such as customized physician, dentistry, podiatry, and other health-related rehabilitation and therapy services. Further, it provides respite care and temporary care and therapy programs. The company was formerly known as Capital Senior Living Corporation and changed its name to Sonida Senior Living, Inc. in November 2021. Sonida Senior Living, Inc. was founded in 1990 and is based in Dallas, Texas.
- Symbol
- SNDA
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Market cap
- $1.81B
- 52 week range
- 24.95 - 44.39
Valuation
- Share price
- $37.77 (close of 2026-09-23)
- P/E (TTM)
- -6.15x
- Price to book
- 2.08x
- Price to free cash flow
- -34.26x
- Enterprise value
- $3.33B
- Book value per share
- $18.28
Price performance
| Period | Change |
|---|
| 1 day | -0.92% |
| 5 days | -4.84% |
| 1 month | -4.52% |
| 3 months | +3.08% |
| 6 months | +19.37% |
| Year to date | +15.82% |
| 1 year | +32.34% |
| 3 years | +285.41% |
| 5 years | +14.56% |
| 10 years | -85.25% |
| All time | -84.97% |
Profitability and growth
- Return on equity
- -1413.88%
- Return on assets
- -8.38%
- Net margin
- -18.57%
- EBITDA margin
- -3.59%
- Revenue growth
- 25.24%
- Net income growth
- -3337.54%
- Free cash flow growth
- 66.90%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- -2.92%
- Current ratio
- 0.88x
- Net debt to EBITDA
- 61.23x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $381.14M
- EBITDA
- $-13.68M
- Net income
- $-70.78M
- Earnings per share
- $-4.22
- Shares outstanding
- 18.09M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|
| 2025-12-31 | $381.14M | - | $-70.78M | $-4.22 |
| 2024-12-31 | $304.33M | $102.79M | $-2.06M | $-0.54 |
| 2023-12-31 | $255.32M | $90.10M | $-21.11M | $-3.85 |
| 2022-12-31 | $238.43M | - | $-54.40M | $-9.27 |
| 2021-12-31 | $234.72M | - | $125.61M | $38.24 |
| 2020-12-31 | $383.86M | - | $-295.37M | $-144.08 |
| 2019-12-31 | $447.10M | $12.83M | $-36.03M | $-17.87 |
| 2018-12-31 | $460.02M | $34.56M | $-53.60M | $-26.97 |
| 2017-12-31 | $467.00M | $31.42M | $-44.17M | $-22.50 |
| 2016-12-31 | $447.45M | $38.06M | $-28.02M | $-14.55 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|
| 2025-12-31 | - | -18.57% | -1413.88% | - |
| 2024-12-31 | 33.78% | -0.68% | -2.63% | 9.60% |
| 2023-12-31 | 35.29% | -8.27% | 18.34% | 11.30% |
| 2022-12-31 | - | -22.82% | 53.48% | - |
| 2021-12-31 | - | 53.51% | -268.33% | - |
| 2020-12-31 | - | -76.95% | 105.77% | - |
| 2019-12-31 | 2.87% | -8.06% | -250.57% | -5.99% |
| 2018-12-31 | 7.51% | -11.65% | -151.98% | 192.19% |
| 2017-12-31 | 6.73% | -9.46% | -54.91% | 8.51% |
| 2016-12-31 | 8.51% | -6.26% | -23.96% | 16.84% |
Cash and debt by year
| Period end | Cash | Debt |
|---|
| 2025-12-31 | $11.01M | $682.45M |
| 2024-12-31 | $16.99M | $635.90M |
| 2023-12-31 | $4.08M | $587.10M |
| 2022-12-31 | $16.91M | $625.00M |
| 2021-12-31 | $78.69M | $613.34M |
| 2020-12-31 | $17.89M | $604.73M |
| 2019-12-31 | $23.98M | - |
| 2018-12-31 | $31.31M | - |
| 2017-12-31 | $17.65M | - |
| 2016-12-31 | $34.03M | - |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|
| 2025-12-31 | $-8.92M | $5.05M |
| 2024-12-31 | $-26.95M | $4.37M |
| 2023-12-31 | $-7.25M | $2.75M |
| 2022-12-31 | $-27.14M | $4.33M |
| 2021-12-31 | $-39.24M | $2.81M |
| 2020-12-31 | $-22.43M | $1.72M |
| 2019-12-31 | $-15.08M | $2.51M |
| 2018-12-31 | $14.90M | $8.43M |
| 2017-12-31 | $15.63M | $7.68M |
| 2016-12-31 | $-10.09M | $11.64M |
Investor relations
Next earnings report
- Next confirmed report
- 2026-11-09
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|
| 2026-08-10 | Jun/2026 | - |
| 2026-05-11 | - | - |
| 2026-03-11 | - | - |
| 2025-11-10 | - | - |
| 2025-08-11 | - | - |
| 2025-05-12 | - | - |
| 2025-03-17 | - | - |
| 2024-11-13 | - | - |
Filings and sources
- Company website
- sonidaseniorliving.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Vertex Pharmaceuticals Inc (VRTX) · Regeneron Pharmaceuticals, Inc. (REGN) · Moderna, Inc. (MRNA) · Incyte Corp (INCY) · Bio-Techne Corp (TECH)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades